Literature DB >> 23338956

Severe bradycardia and syncope due to topical ophthalmic timolol.

U Canpolat1, K M Gürses, K Aytemir, A Oto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23338956     DOI： 10.1007/s00059-012-3725-7

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  3 in total

1.  Syncope, bradycardia, and atrioventricular block associated with topical ophthalmic levobunolol.

Authors:  J G Chun; M A Brodsky; B J Allen
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

2.  [Atrioventricular block secondary to topical ophthalmic beta blockers].

Authors:  J M Rubín López; S Hevía Nava; A Veganzones Bayón; V Barriales Alvarez
Journal:  Rev Esp Cardiol       Date:  1999-07       Impact factor: 4.753

Review 3.  Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects.

Authors:  T Nieminen; T Lehtimäki; J Mäenpää; A Ropo; H Uusitalo; M Kähönen
Journal:  Scand J Clin Lab Invest       Date:  2007       Impact factor: 1.713
  3 in total
  1 in total

1.  Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.

Authors:  Narendranath Epperla; Murray H Brilliant; Humberto Vidaillet
Journal:  BMJ Case Rep       Date:  2014-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.